Kenvue Inc. (NYSE:KVUE) Shares Sold by Violich Capital Management Inc.

Violich Capital Management Inc. cut its stake in shares of Kenvue Inc. (NYSE:KVUE) by 10.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 36,114 shares of the company’s stock after selling 4,415 shares during the period. Violich Capital Management Inc.’s holdings in Kenvue were worth $771,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Huntington National Bank increased its position in shares of Kenvue by 26.5% during the third quarter. Huntington National Bank now owns 4,161 shares of the company’s stock valued at $96,000 after acquiring an additional 871 shares during the last quarter. ING Groep NV grew its holdings in shares of Kenvue by 23.6% in the third quarter. ING Groep NV now owns 3,576,616 shares of the company’s stock valued at $82,727,000 after purchasing an additional 681,954 shares in the last quarter. Everence Capital Management Inc. grew its holdings in shares of Kenvue by 122.1% in the fourth quarter. Everence Capital Management Inc. now owns 45,380 shares of the company’s stock valued at $969,000 after purchasing an additional 24,950 shares in the last quarter. Tyler Stone Wealth Management grew its holdings in shares of Kenvue by 134.4% in the third quarter. Tyler Stone Wealth Management now owns 49,050 shares of the company’s stock valued at $1,135,000 after purchasing an additional 28,125 shares in the last quarter. Finally, Saturna Capital Corp grew its holdings in shares of Kenvue by 29.9% in the third quarter. Saturna Capital Corp now owns 1,334,860 shares of the company’s stock valued at $30,875,000 after purchasing an additional 307,039 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Piper Sandler upgraded shares of Kenvue from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $21.00 to $26.00 in a report on Monday, January 6th. Canaccord Genuity Group dropped their price objective on shares of Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a report on Friday. Barclays dropped their price objective on shares of Kenvue from $23.00 to $21.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Citigroup lowered their price target on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating for the company in a report on Wednesday, January 15th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $24.00 price target on shares of Kenvue in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, Kenvue has an average rating of “Hold” and an average price target of $23.00.

Kenvue Stock Up 2.1 %

Shares of NYSE:KVUE opened at $20.60 on Tuesday. The company has a market capitalization of $39.49 billion, a PE ratio of 38.86, a P/E/G ratio of 2.16 and a beta of 1.45. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46. The firm has a 50 day simple moving average of $21.54 and a 200-day simple moving average of $22.00.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, equities analysts predict that Kenvue Inc. will post 1.05 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be given a $0.205 dividend. The ex-dividend date is Wednesday, February 12th. This represents a $0.82 annualized dividend and a yield of 3.98%. Kenvue’s dividend payout ratio (DPR) is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.